Retrophin Inc (NASDAQ:RTRX)

19.20
Delayed Data
As of Aug 07
 +0.09 / +0.47%
Today’s Change
8.98
Today|||52-Week Range
21.92
+35.21%
Year-to-Date
Retrophin EPS beats by $0.14, beats on revenue
Jul 30 / Seeking Alpha - Paid Partner Content
 

Today’s Trading

Previous close19.11
Today’s open19.31
Day’s range19.02 - 19.70
Volume16,990
Average volume (3 months)486,106
Market cap$977.4M
Data as of 3:59pm ET, 08/07/2020

Growth & Valuation

Earnings growth (last year)-36.19%
Earnings growth (this year)+16.51%
Earnings growth (next 5 years)+137.00%
Revenue growth (last year)+6.75%
P/E ratioNM
Price/Sales3.43
Price/Book3.74

Competitors

 Today’s
change
Today’s
% change
VBIVVBI Vaccines Inc+0.04+0.95%
REPLReplimune Group Inc+2.25+10.52%
VXRTVaxart Inc+0.12+1.26%
ATRAAtara Biotherapeutic...+0.14+1.12%
Data as of 6:20pm ET, 08/07/2020

Financials

Next reporting dateOctober 29, 2020
EPS forecast (this quarter)-$0.49
Annual revenue (last year)$175.3M
Annual profit (last year)-$146.4M
Net profit margin-83.51%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
San Diego, California

Forecasts